Cargando…
Overexpression of Msx1 in Mouse Lung Leads to Loss of Pulmonary Vessels Following Vascular Hypoxic Injury
Pulmonary arterial hypertension (PAH) is a progressive lung disease caused by thickening of the pulmonary arterial wall and luminal obliteration of the small peripheral arteries leading to increase in vascular resistance which elevates pulmonary artery pressure that eventually causes right heart fai...
Autores principales: | West, James, Rathinasabapathy, Anandharajan, Chen, Xinping, Shay, Sheila, Gladson, Shanti, Talati, Megha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8471093/ https://www.ncbi.nlm.nih.gov/pubmed/34571956 http://dx.doi.org/10.3390/cells10092306 |
Ejemplares similares
-
rhACE2 Therapy Modifies Bleomycin-Induced Pulmonary Hypertension via Rescue of Vascular Remodeling
por: Rathinasabapathy, Anandharajan, et al.
Publicado: (2018) -
Ubiquitin chains: a new way of screening for regulatory differences in pulmonary hypertension
por: Rathinasabapathy, Anandharajan, et al.
Publicado: (2018) -
Expression of a Human Caveolin-1 Mutation in Mice Drives Inflammatory and Metabolic Defect-Associated Pulmonary Arterial Hypertension
por: Rathinasabapathy, Anandharajan, et al.
Publicado: (2020) -
Adverse effects of BMPR2 suppression in macrophages in animal models of pulmonary hypertension
por: West, James, et al.
Publicado: (2020) -
Idiopathic and heritable PAH perturb common molecular pathways, correlated with increased MSX1 expression
por: Austin, Eric D., et al.
Publicado: (2011)